Home
>
News
>
Corporate Results
>
shukra pharmaceuticals reports consolidated net loss of rs 1 72 crore in the march 2026 quarter

Shukra Pharmaceuticals Reports Consolidated Net Loss Of Rs 1.72 Crore In The March 2026 Quarter

08-May-26 07:36 Hrs IST

Net loss of Shukra Pharmaceuticals reported to Rs 1.72 crore in the quarter ended March 2026 as against net profit of Rs 5.39 crore during the previous quarter ended March 2025. Sales declined 52.37% to Rs 6.32 crore in the quarter ended March 2026 as against Rs 13.27 crore during the previous quarter ended March 2025.

For the full year,net profit rose 130.27% to Rs 22.06 crore in the year ended March 2026 as against Rs 9.58 crore during the previous year ended March 2025. Sales rose 74.07% to Rs 56.73 crore in the year ended March 2026 as against Rs 32.59 crore during the previous year ended March 2025.

Particulars	Quarter Ended			Year Ended
	Mar. 2026	Mar. 2025	% Var.	Mar. 2026	Mar. 2025	% Var.
Sales	6.32	13.27	-52	56.73	32.59	74
OPM %	11.08	55.09	-	50.66	39.06	-
PBDT	1.39	8.51	-84	32.23	16.34	97
PBT	0.38	7.57	-95	28.79	13.34	116
NP	-1.72	5.39	PL	22.06	9.58	130

Powered by Capital Market - Live News

Invest with clarity

on Chola Securities Mobile & Web App.

Stay organised, informed & in control while accessing your portfolio, reports, trading tools and service requests—all in one seamless platform.

Download the app now → The new app is listed as Chola Securities- Prime Access on App store & Google Play.
Also available on Web, Click to explore